FOSTER CITY, Calif. & WOBURN, Mass.--(BUSINESS WIRE)--Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced that it has signed a non-exclusive reseller agreement with BioTrove, Inc. to offer an end-to-end mass spectrometry-based drug discovery workflow intended to help pharmaceutical companies make drug discovery more efficient. This solution will combine BioTrove’s RapidFire™ Mass Spectrometry Sample Preparation System with industry-leading mass spectrometers from Applied Biosystems and its joint-venture partner, MDS Analytical Technologies, a business unit of MDS Inc. (NYSE:MDZ)(TSX:MDS).
